1. Imidazoacridinone antitumor agent C-1311 as a selective mechanism-based inactivator of human cytochrome P450 1A2 and 3A4 isoenzymes

   • Agnieszka Potęga
   • Barbara Fedejko-Kap
   • Zofia Mazerska

   Original Research Article 16 March 2016 Pages: 663 - 670

2. Natural terpenoids as a promising source for modulation of GABAergic system and treatment of neurological diseases

   • Azadeh Manayi
   • Seyed Mohammad Nabavi
   • Samineh Jafari

   Review Article 08 April 2016 Pages: 671 - 679

3. Influence of caffeine on the protective activity of gabapentin and topiramate in a mouse model of generalized tonic-clonic seizures

   • Magdalena Chrościńska-Krawczyk
   • Małgorzata Jargiełło-Baszak
   • Stanisław J. Czuczwar

   Original Research Article 26 March 2016 Pages: 680 - 685

4. Opioid-induced redistribution of 6TM and 7TM μ opioid receptors: A hypothesized mechanistic facilitator model of opioid-induced hyperalgesia

   • Wei Wang
   • Yan Wang
   • Fuzhou Wang

   Review Article 19 March 2016 Pages: 686 - 691

5. Peroxisome proliferator-activated receptor-α stimulation by clofibrate favors an antioxidant and vasodilator environment in a stressed left ventricle

   • Luz Ibarra-Lara
   • Leonardo Del Valle-Mondragón
   • Alicia Sánchez-Mendoza

   Original Research Article 21 March 2016 Pages: 692 - 702

6. Pharmacotherapy in detrusor underactivity: A new challenge for urologists and pharmacologists (from lab to clinic)

   • Kajetan Juszczak
   • Tomasz Drewa

   Review Article 19 March 2016 Pages: 703 - 706

7. Narrow time window of metabolic changes associated with transition to overt heart failure in Tgaq*44 mice

   • Elżbieta Czarnowska
   • Joanna B. Bierła
   • Stefan Chłopicki

   Original Research Article 28 March 2016 Pages: 707 - 714

8. Circulatory effect of TCS-80, a new imidazoline compound, in rats

   • Konrad Boblewski
   • Artur Lehmann
   • Apolonia Rybczyńska

   Short Communication 23 March 2016 Pages: 715 - 719

9. Effect of trans-chalcone on atheroma plaque formation, liver fibrosis and adiponectin gene expression in cholesterol-fed NMRI mice

   • Leyla Karkhaneh
   • Parichehreh Yaghmaei
   • Azadeh Ebrahim-Habibi

   Original Research Article 18 March 2016 Pages: 720 - 727

10. l-NAME differential effects on diazepam and flunitrazepam responses of rats in the object recognition test

    • Jolanta Orzelska-Gorka
    • Sylwia Talarek
    • Sylwia Fidecka

    Short Communication 29 March 2016 Pages: 728 - 732

11. Pharmacokinetics of paracetamol in patients with chronic pancreatitis

    • Magdalena Siepsiak
    • Edyta Szałek
    • Edmund Grześkowiak

    Short Communication 23 March 2016 Pages: 733 - 736

12. Current and future trends in the lipid lowering therapy

    • Bogusław Okopień
    • Łukasz Bułdak
    • Aleksandra Bołdys

    Review Article 13 April 2016 Pages: 737 - 747

13. Lurasidone: The 2016 update on the pharmacology, efficacy and safety profile

    • Rafał R. Jaeschke
    • Magdalena Sowa-Kućma
    • Wojciech Datka

    Review Article 22 April 2016 Pages: 748 - 755

14. A study of chemokines, chemokine receptors and interleukin-6 in patients with panic disorder, personality disorders and their co-morbidity

    • Ewa A. Ogłodek
    • Anna M. Szota
    • Aleksander Araszkiewicz

    Original Research Article 12 April 2016 Pages: 756 - 763

15. Possible neuroprotective mechanisms of clove oil against icv-colchicine induced cognitive dysfunction

    • Anil Kumar
    • Archi Aggrawal
    • Arti Singh

    Original Research Article 19 March 2016 Pages: 764 - 772

16. Transdermal immunotherapy: Past, present and future

    • Marian Szczepanik
    • Monika Majewska-Szczepanik

    Review Article 25 April 2016 Pages: 773 - 781

17. Allopurinol decreases serum uric acid level and intestinal glucose transporter-5 expression in rats with fructose-induced hyperuricemia

    • Gang Chen
    • Ping Jia

    Original Research Article 06 May 2016 Pages: 782 - 786

18. Inflammatory bowel disease treatment

    • Jakub Fichna

    Editorial 24 May 2016 Pages: 787 - 788

19. Janus kinases in inflammatory bowel disease: Four kinases for multiple purposes

    • René Galien

    Review Article 22 April 2016 Pages: 789 - 796

20. Pharmacology and metabolism of infliximab biosimilars — A new treatment option in inflammatory bowel diseases

    • Marcin Włodarczyk
    • Jakub Fichna
    • Aleksandra Sobolewska-Włodarczyk

    Review Article 26 April 2016 Pages: 797 - 801

21. LL-37: Cathelicidin-related antimicrobial peptide with pleiotropic activity

    • Adam Fabisiak
    • Natalia Murawska
    • Jakub Fichna

    Review Article 07 April 2016 Pages: 802 - 808

22. Is insulin-like growth factor 1 (IGF-1) system an attractive target inflammatory bowel diseases? Benefits and limitation of potential therapy

    • Hubert Zatorski
    • Mateusz Marynowski
    • Jakub Fichna

    Review Article 18 March 2016 Pages: 809 - 815

23. Food, nutrients and nutraceuticals affecting the course of inflammatory bowel disease

    • José Antonio Uranga
    • Visitación López-Miranda
    • Raquel Abalo

    Review Article 03 June 2016 Pages: 816 - 826

24. Can exercise affect the course of inflammatory bowel disease? Experimental and clinical evidence

    • Jan Bilski
    • Agnieszka Mazur-Bialy
    • Tomasz Brzozowski

    Review Article 02 May 2016 Pages: 827 - 836

25. Common links between metabolic syndrome and inflammatory bowel disease: Current overview and future perspectives

    • Arkadiusz Michalak
    • Paula Mosińska
    • Jakub Fichna

    Review Article 09 May 2016 Pages: 837 - 846

26. Circadian rhythm abnormalities — Association with the course of inflammatory bowel disease

    • Aleksandra Sobolewska-Włodarczyk
    • Marcin Włodarczyk
    • Maria Wiśniewska-Jarosińska

    Review Article 28 April 2016 Pages: 847 - 851

27. The influence of family pattern abnormalities in the early stages of life on the course of inflammatory bowel diseases

    • Marcin Włodarczyk
    • Aleksandra Sobolewska-Włodarczyk
    • Maria Wiśniewska-Jarosińska

    Review Article 30 April 2016 Pages: 852 - 858

28. Inflammatory bowel diseases and reproductive health

    • Agnieszka Kokoszko-Bilska
    • Slawomir Sobkiewicz
    • Jakub Fichna

    Review Article 25 March 2016 Pages: 859 - 864